Acinetobacter baumannii at a tertiary-care teaching hospital in Jerusalem, Israel

A. Simhon*, G. Rahav, G. Shazberg, C. Block, H. Bercovier, M. Shapiro

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Abstract

In a retrospective 10-year analysis of 3,536 patient-unique isolates, Acinetobacter baumannii imipenem susceptibility declined from 98.1 (1990) to 64.1% (2000), and ciprofloxacin susceptibility decreased from 50.5 to 13.1%. Imipenem median zone diameters decreased from 27.7 (1997) to 18.8 mm (2000). No outbreaks were detected. Two clusters were identified for 41 strains genotyped by pulsed-field gel electrophoresis, but imipenem resistance was not clonal.

Original languageEnglish
Pages (from-to)389-391
Number of pages3
JournalJournal of Clinical Microbiology
Volume39
Issue number1
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Dive into the research topics of 'Acinetobacter baumannii at a tertiary-care teaching hospital in Jerusalem, Israel'. Together they form a unique fingerprint.

Cite this